Cargando…
Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria
Infections caused by nontuberculous mycobacteria (NTM) are increasing worldwide, resulting in a new global health concern. NTM treatment is complex and requires combinations of several drugs for lengthy periods. In spite of this, NTM disease is often associated with poor treatment outcomes. The anti...
Autores principales: | Muñoz-Muñoz, Lara, Shoen, Carolyn, Sweet, Gaye, Vitoria, Asunción, Bull, Tim J., Cynamon, Michael, Thompson, Charles J., Ramón-García, Santiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066277/ https://www.ncbi.nlm.nih.gov/pubmed/33916775 http://dx.doi.org/10.3390/antibiotics10040381 |
Ejemplares similares
-
Engineered biosynthesis of milbemycins in the avermectin high-producing strain Streptomyces avermitilis
por: Kim, Myoun-Su, et al.
Publicado: (2017) -
Genetic Determinants of Tigecycline Resistance in Mycobacteroides abscessus
por: Ng, Hien Fuh, et al.
Publicado: (2022) -
A mouse model of pulmonary Mycobacteroides abscessus infection
por: Maggioncalda, Emily C., et al.
Publicado: (2020) -
Tracheobronchopathia Osteochondroplastica Complicated with Mycobacteroides abscessus Pulmonary Disease
por: Yoshida, Seiji, et al.
Publicado: (2021) -
Development of a penem antibiotic against Mycobacteroides abscessus
por: Batchelder, Hunter R., et al.
Publicado: (2020)